Grant: Master's Award: Canada Graduate Scholarships
Université Laval
$17,500.00
Modulation of CD103 expression on dendritic cells in airway allergic inflammatory disease
FY 2014-15
Summary
Asthma is an important disease characterized by airway inflammation. CD103 is a protein which plays an important role in the regulation of the intensity and duration of this inflammatory response. CD103 is expressed on immunologic cells (dendritic cells and T cells) which are present in the lung. Recently, using mouse models, we demonstrated that it is involved in the control of asthma severity. These results suggest that CD103 could be used as a therapeutic target to regulate asthma. However, very little is known of the specific signals which induce CD103 expression in the lung. In this project, we focus on identifying the mechanisms by which CD103 expression can be induced by various molecules or cell populations. Our hypothesis is that the expression of CD103 on dendritic cells could be induced by inflammatory molecules or the close presence of the airway epithelium in asthma. This project will allow us to shine a light on CD103 as a potential target for the treatment of airway inflammatory diseases.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331609
Name
Brassard Julyanne
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modulation of CD103 expression on dendritic cells in airway allergic inflammatory disease
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Airway Epithelial Cells; Asthma; Cd103; Cell Culture; Dendritic Cells; E-Cadherine; Flow Cytometry; Immunofluorescence; Lung; Western Blot
Abstract
Asthma is an important disease characterized by airway inflammation. CD103 is a protein which plays an important role in the regulation of the intensity and duration of this inflammatory response. CD103 is expressed on immunologic cells (dendritic cells and T cells) which are present in the lung. Recently, using mouse models, we demonstrated that it is involved in the control of asthma severity. These results suggest that CD103 could be used as a therapeutic target to regulate asthma. However, very little is known of the specific signals which induce CD103 expression in the lung. In this project, we focus on identifying the mechanisms by which CD103 expression can be induced by various molecules or cell populations. Our hypothesis is that the expression of CD103 on dendritic cells could be induced by inflammatory molecules or the close presence of the airway epithelium in asthma. This project will allow us to shine a light on CD103 as a potential target for the treatment of airway inflammatory diseases.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brassard, Julyanne
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~